Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-13-030221)

Filing Details

Accession Number:: 0001127602-13-030221
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-11-01 17:07:17
Reporting Period:: 2013-11-01

Filing Date:: 2013-11-01
Accepted Time:: 2013-11-01 17:07:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1520262	Alkermes Plc.	ALKS	Pharmaceutical Preparations (2834)	981007018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236441	A Robert Breyer	Connaught House 1 Burlington Road Dublin 4 Ireland		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2013-11-01	5,000	$14.04	59,506	No	4	M	Direct
Ordinary Shares	Disposition	2013-11-01	5,000	$35.26	54,506	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Non Qualified Stock Option (Right to Buy)	Disposition	2013-11-01	5,000	$0.00	5,000	$14.04

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,400		2016-09-21	No	4	M	Direct

Footnotes

This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
These options are fully vested in accordance with their terms.